274 related articles for article (PubMed ID: 19703357)
1. Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.
Stasiak P; Ehrhardt C; Juzwa M; Sznitowska M
J Pharm Pharmacol; 2009 Aug; 61(8):1119-24. PubMed ID: 19703357
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and hydrolytic behaviour of 2-mercaptoethyl ibuprofenate-polyethylene glycol conjugate as a novel transdermal prodrug.
Davaran S; Rashidi MR; Hashemi M
J Pharm Pharmacol; 2003 Apr; 55(4):513-7. PubMed ID: 12803773
[TBL] [Abstract][Full Text] [Related]
3. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
[TBL] [Abstract][Full Text] [Related]
4. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
Adeyeye CM; Price JC
J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric Acid) conjugates with the model compound Ibuprofen.
Stasiak P; Sznitowska M; Ehrhardt C; Luczyk-Juzwa M; Grieb P
AAPS PharmSciTech; 2010 Dec; 11(4):1636-41. PubMed ID: 21088943
[TBL] [Abstract][Full Text] [Related]
6. Lactic acid oligomers (OLAs) as prodrug moieties.
Kruse J; Lachmann B; Lauer R; Eppacher S; Noe CR
Pharmazie; 2013 Feb; 68(2):93-9. PubMed ID: 23469680
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and in vitro evaluation of vinyl ether type polymeric prodrugs of ibuprofen, ketoprofen and naproxen.
Babazadeh M
Int J Pharm; 2008 May; 356(1-2):167-73. PubMed ID: 18289807
[TBL] [Abstract][Full Text] [Related]
8. Stability studies of some glycolamide ester prodrugs of niflumic acid in aqueous buffers and human plasma by HPLC with UV detection.
Talath S; Shirote PJ; Lough WJ; Gadad AK
Arzneimittelforschung; 2006; 56(9):631-9. PubMed ID: 17063638
[TBL] [Abstract][Full Text] [Related]
9. Alkyl ester prodrugs for improved topical delivery of ibuprofen.
Bansal AK; Khar RK; Dubey R; Sharma AK
Indian J Exp Biol; 2001 Mar; 39(3):280-3. PubMed ID: 11495290
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Lamprecht A; Saumet JL; Roux J; Benoit JP
Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
[TBL] [Abstract][Full Text] [Related]
11. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of hydrophilic intra-articular microspheres conjugated to ibuprofen and evaluation of anti-inflammatory activity on articular explants.
Bédouet L; Moine L; Pascale F; Nguyen VN; Labarre D; Laurent A
Int J Pharm; 2014 Jan; 459(1-2):51-61. PubMed ID: 24231051
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and stability of dendrimer prodrugs.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2006 Feb; 308(1-2):175-82. PubMed ID: 16384673
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activity and hydrolysis behavior of novel ibuprofen glucopyranoside conjugates.
Zhao X; Tao X; Wei D; Song Q
Eur J Med Chem; 2006 Nov; 41(11):1352-8. PubMed ID: 16806590
[TBL] [Abstract][Full Text] [Related]
15. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
[TBL] [Abstract][Full Text] [Related]
16. Introduction of β-cyclodextrin into poly(aspartic acid) matrix for adsorption and time-release of ibuprofen.
Sun ZY; Shen MX; Yang AW; Liang CQ; Wang N; Cao GP
Chem Commun (Camb); 2011 Jan; 47(3):1072-4. PubMed ID: 21079853
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and stability of two indomethacin prodrugs.
Chandrasekaran S; Al-Ghananeem AM; Riggs RM; Crooks PA
Bioorg Med Chem Lett; 2006 Apr; 16(7):1874-9. PubMed ID: 16439128
[TBL] [Abstract][Full Text] [Related]
18. Influence of a lipophilic drug on the stability of emulsions: an important approach on the development of lipidic carriers.
Formiga FR; Fonseca IA; Souza KB; Silva AK; Macedo JP; Araújo IB; Soares LA; Egito ES
Int J Pharm; 2007 Nov; 344(1-2):158-60. PubMed ID: 17614224
[TBL] [Abstract][Full Text] [Related]
19. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
Abioye AO; Kola-Mustapha A; Chi GT; Ilya S
Int J Pharm; 2014 Aug; 471(1-2):453-77. PubMed ID: 24886691
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative properties of ibuprofen-oligo(3-hydroxybutyrate) conjugates.
Zawidlak-Wegrzyńska B; Kawalec M; Bosek I; Łuczyk-Juzwa M; Adamus G; Rusin A; Filipczak P; Głowala-Kosińska M; Wolańska K; Krawczyk Z; Kurcok P
Eur J Med Chem; 2010 May; 45(5):1833-42. PubMed ID: 20171760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
